Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Glycolysis and Bone Formation: From Pathological Mechanisms to Regulatory Strategies.

Created on 13 Nov 2026

Authors

Suzhen Chao, Yili Zhou, Junjie Xia, Nuoping Wu, Shuyu Zhan, Liang Zhang, Bo Liu

Published in

Cell biochemistry and function. Volume 44. Issue 11.

Abstract

Bone homeostasis is maintained by the balance between osteoblast-mediated bone formation and osteoclast-induced bone resorption, and reduced osteoblastic activity contributes to osteoporosis (OP) and other bone disorders. Energy metabolism, especially glycolysis, has emerged as a critical regulator of osteoblast function and bone formation, yet its integrated role in physiological and pathological bone metabolism remains to be systematically defined. Here, we summarize the multi-faceted mechanisms by which glycolysis modulates bone formation: glucose metabolic shifts during osteoblast differentiation, provision of energy substrates and metabolic intermediates for osteoblastic activities, regulation of glycolytic enzyme expression via key signaling pathways (e.g., Wnt) and transcription factors (HIF-1α, mTOR), and mediation of metabolism-differentiation crosstalk by non-coding RNAs, including microRNAs (miRNAs) and lncRNAs, through targeted glycolytic gene regulation. In OP, glycolytic remodeling exacerbates impaired bone formation, and targeting pivotal glycolytic nodes for metabolic reprogramming holds great promise for developing novel osteoanabolic therapies against bone diseases. SIGNIFICANCE STATEMENT: Bone formation is an energy-intensive process, yet the vital role of glycolysis in driving osteoblast function is often underestimated. This review elucidates how glucose metabolism fuels bone formation, serving not only as an energy source but also as a critical regulator of cell differentiation. We synthesize evidence linking specific metabolic enzymes and signaling networks to skeletal health and demonstrate how these pathways are disrupted in diseases like osteoporosis. This work is important because it establishes a clear framework connecting cellular metabolism to bone pathology. By identifying key metabolic nodes as therapeutic targets, we offer a roadmap for developing novel strategies to treat bone disorders through metabolic reprogramming.

PMID:
43019083
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement